Infectious Disease
Plexus Vaccine Licenses Molsoft To Develop Proprietary Virtual Epitope Databases
Published in TB and Outbreaks Week, October 16th, 2001
Plexus Vaccine Inc. and Molsoft LLC have entered into a key licensing agreement to discover and commercialize new interventional strategies for global infectious diseases, for drug-resistant microbes, and for chronic diseases associated with cryptic pathogens. Using the Molsoft ICM software suite, Plexus is developing Virtual Epitope databases of molecular disease targets for in silico design of structural mimics that can be readily synthesized, tested, and formulated as vaccines.
"This alliance represents an opportunity to use Molsoft's molecular modeling software and Plexus Vaccine's structure-based vaccine design to develop epitope-specific vaccines that generate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Kidney Disease
Diabetes, Cyclosporine Use Are Risk Factors For Posttransplant Tuberculosis - Tuberculous Kyphosis
Single-Stage Decompression Surgery Effective - AIDS/HIV Tuberculosis
Italian Prevention Guidelines Effective, But Underused - Drug Development
Antiviral Peptides Potentially Useful Against STDs - Mycobacterial Infection
Immune Response Includes Matrix Metalloproteinase Production - Pesticide Poisoning
Illnesses Associated With Use Of Plant Growth Regulator - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
